Control of spasticity in a multiple sclerosis model using central nervous system‐excluded CB 1 cannabinoid receptor agonists

2013 ◽  
Vol 28 (1) ◽  
pp. 117-130 ◽  
Author(s):  
Gareth Pryce ◽  
Cristina Visintin ◽  
Sreeram V. Ramagopalan ◽  
Sarah Al‐Izki ◽  
Lia E. De Faveri ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Cannabinoid Receptor ◽  
Receptor Agonists ◽  
Multiple Sclerosis Model

Trichuris suis secrete products that reduce disease severity in a multiple sclerosis model

2017 ◽  
Vol 62 (1) ◽  
Author(s):  
Christine Søholm Hansen ◽  
Henrik Hasseldam ◽  
Idahella Hyldgaard Bacher ◽  
Stig Milan Thamsborg ◽  
Flemming Fryd Johansen ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Disease Severity ◽  
Western World ◽  
Cns Disease ◽  
High Prevalence ◽  
High Level ◽  
Reduce Disease Severity ◽  
Multiple Sclerosis Model

AbstractMultiple sclerosis is a chronic inflammatory central nervous system (CNS) disease, which affects about 1 in 1000 individuals in the western world. It has been suggested that this relatively high prevalence is linked to a high level of hygiene,

Multiple Sclerosis Is Rare in Epstein–Barr Virus–Seronegative Children with Central Nervous System Inflammatory Demyelination

2021 ◽  
Author(s):  
Bardia Nourbakhsh ◽  
Christian Cordano ◽  
Carlo Asteggiano ◽  
Klemens Ruprecht ◽  
Carolin Otto ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Epstein Barr Virus ◽  
Barr Virus ◽  
Epstein Barr

First Presentation of an Acquired Demyelinating Syndrome

2017 ◽  
Vol 16 (03) ◽  
pp. 164-170
Author(s):  
Rachel Gottlieb-Smith ◽  
Amy Waldman
Keyword(s):  
Multiple Sclerosis ◽  
Central Nervous System ◽  
Nervous System ◽  
Differential Diagnosis ◽  
Optic Neuritis ◽  
Clinical Features ◽  
Neuromyelitis Optica ◽  
Transverse Myelitis ◽  
Acute Disseminated Encephalomyelitis ◽  
The Central Nervous System

AbstractAcquired demyelinating syndromes (ADS) present with acute or subacute monofocal or polyfocal neurologic deficits localizing to the central nervous system. The clinical features of distinct ADS have been carefully characterized including optic neuritis, transverse myelitis, and acute disseminated encephalomyelitis. These disorders may all be monophasic disorders. Alternatively, optic neuritis, partial transverse myelitis, and acute disseminated encephalomyelitis may be first presentations of a relapsing or polyphasic neuroinflammatory disorder, such as multiple sclerosis or neuromyelitis optica. The clinical features of these disorders and the differential diagnosis are discussed in this article.

Sign in / Sign up

Export Citation Format

Share Document